Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]
Plante DT +10 more
europepmc +1 more source
Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims. [PDF]
Markt SC +11 more
europepmc +1 more source
In recent years, hypersomnia patients and researchers alike have increasingly discussed the possibility of heightened comorbidities, or co-occurrences, of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) with the central
Mikkelsen, Sophie Sevan
core
Xywav: A Treatment Option for Idiopathic Hypersomnia in Down Syndrome. [PDF]
Sanchez S, Allen J.
europepmc +1 more source
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia. [PDF]
Mignot E +8 more
europepmc +1 more source
Narcolepsy type 2 is an unstable diagnosis and idiopathic hypersomnia has the potential for remission-long-term and cross-sectional observations from the Bern Sleep-Wake Registry. [PDF]
Cavalli RG +6 more
europepmc +1 more source
The experience and impact of living with idiopathic hypersomnia: A qualitative study of patient perspectives shared in online media. [PDF]
Bermingham SL +3 more
europepmc +1 more source
Mood Disorders and Dysautonomia in Patients Diagnosed with Idiopathic Hypersomnia: A Retrospective Analysis (2000-2023). [PDF]
Rochart R +4 more
europepmc +1 more source
AMCP Market Insights: Payer best practices for timely diagnosis and optimal management of idiopathic hypersomnia. [PDF]
Flavin B +6 more
europepmc +1 more source
Moving the dial on behavioral interventions for idiopathic hypersomnia. [PDF]
Nigam M, Leu-Semenescu S, Arnulf I.
europepmc +1 more source

